Unlocking the genomic and epigenetic variations that drive human health
About Us
Nooma Bio is developing a proprietary dual-nanopore technology that enables scientists to unlock the genome-wide structural and epigenetic variations that drive human health. Our core platform produces ultra high-resolution genome and epigenome maps by performing repetitive electronic scans of oligo-tagged DNA molecules in a matter of seconds. We are privately held and headquartered in Santa Cruz, Calif.
Leadership Team
-
Kevin Corcoran, Chief Executive Officer
-
William Dunbar, PhD, Founder and Chief Technology Officer
-
Paul Lundquist, PhD, Senior Vice President of Engineering
-
Kathy Lazaruk, PhD, Senior Director of Biochemistry
-
Razvan Chirita PhD, Senior Director of Software and Bioinformatics
Scientific Publications
-
Electronic Mapping of a Bacterial Genome with Dual Solid-State Nanopores and Active Single-Molecule Control (2021) A Rand, P Zimny, R Nagel, C Telang, J Mollison, A Bruns, E Leff, W Reisner and WB Dunbar (ACS Nano 2022, 16, 4, 5258–5273)
-
Flossing DNA in a Dual Nanopore Device (2020) X Liu, P Zimny, Y Zhang, A Rana, R Nagel, W Reisner and WB Dunbar
-
Controlling DNA Tug-of-War in a Dual Nanopore Device (2019) X Liu, Y Zhang, R Nagel, W Reisner and WB Dunbar